Cat. No. Name Size Price Add Cart
KI0006PTC12410 mg$150
PTC12425 mg$300
PTC124100 mg$330
PTC124100 mg$592

Chemical Characteristic

Product NamePTC124
SynonymsAtaluren
CAS No.775304-57-9
Molecular Weight 284.24
FormulaC15H9FN2O3
Chemical Name3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
Smilesc1c(cccc1C(=O)O)c1noc(n1)c1ccccc1F
Chemical Structure
DocumentsHNMR- DMSO LCMS

Biological activities

PTC124 is a potent firefly luciferase (FLuc) inhibitor. The IC50 of with PTC124 is 7 nM against FLuc. PTC124 is used as a potent nonsense-suppressing agent. PTC124 is a new chemical entity that selectively induces ribosomal read-through of premature but not normal termination codons. PTC124 (2 µM) slows the proteolysis half-life of firefly luciferase by about 2-fold but shows no effect on the proteolysis half-life of Renilla reniformis luciferase (RLuc).[1] PTC124 promotes dose-dependent read-through of all three nonsense codons (UAA, UAG or UGA) in stable HEK293 cells harbouring LUC-190 nonsense alleles. The minimal concentration of PTC124 showing discernable readthrough is 0.01-0.1 µM (2.8-28 ng/mL), whereas the concentration promoting maximal activity is approximately 3 µM (852 ng/mL). PTC124 promotes suppression of human and mouse nonsense alleles of the dystrophin gene. In primary cell cultures derived from muscle biopsies, 17 µM (5 µg/mL) of PTC124 has the most efficient read-through and there is no further increase at 10 µg/mL. The ratio of dystrophin:myosin obtained at 5 µg/mL of PTC124 is 40-60% of normal. For the samples from a model of Duchenne muscular dystrophy (DMD), the dystrophin:myosin ratio is approximately 35% of normal at 10 µg/mL. In the model of Duchenne muscular dystrophy, either intraperitoneal injections or oral dosing alone of PTC124 results in partial protection against contraction-induced injury in the extensor digitorum longus (EDL) muscles.[2] In a mouse model for cystic fibrosis (CF), s.c. injection or oral administration of PTC124 (15, 30, or 60 mg/kg) to Cftr -/- mice expressing a human cystic fibrosis transmembrane conductance regulator (CFTR)-G542X transgene suppress the G542X nonsense mutation and restore a significant amount of human (h)CFTR protein and function. PTC124 treatment also results in the appearance of hCFTR protein at the apical surface of intestinal glands in Cftr -/- hCFTR-G542X mice. In addition, functional assays demonstrate that PTC124 treatment restores 24-29% of the average cAMP-stimulated transepithelial chloride currents observed in wild-type mice.[3]

Protocols

Stock solutions of PTC124 (6 mM) are prepared in 100% DMSO.[2]

References

[1] Auld DS, et al. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci U S A. 2009, 106(9): 3585-3590.
[2] Welch EM, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007, 447(7140): 87-91.
[3] Du M, et al. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci USA. 2008, 105(6): 2064-2069.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.